Rtw Investments, LP Zynerba Pharmaceuticals, Inc. Transaction History

Rtw Investments, LP

  • $6.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
$8.49 - $13.46 $1.72 Million - $2.73 Million
-202,859 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$8.69 - $14.59 $24,844 - $41,712
2,859 Added 1.43%
202,859 $2.54 Million
Q3 2017

Nov 14, 2017
BUY
$5.73 - $9.44 $1.15 Million - $1.89 Million
200,000
200,000 $1.67 Million

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email